{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:04:14Z","timestamp":1791335054105,"version":"4.3.1"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.2215\/cjn.12571213","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T01:12:17Z","timestamp":1396573937000},"page":"1479-1487","source":"Crossref","is-referenced-by-count":52,"title":["De Novo Glomerular Diseases after Renal Transplantation"],"prefix":"10.2215","volume":"9","author":[{"given":"Claudio","family":"Ponticelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Glassock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20230601","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1681\/ASN.2008050454","article-title":"Probability, predictors, and prognosis of posttransplantation glomerulonephritis.","volume":"20","author":"Chailimpamontree","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R2-20-20230601","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2215\/CJN.04050907","article-title":"Recurrent glomerulonephritis after renal transplantation: An unsolved problem.","volume":"3","author":"Golgert","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-20-20230601","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/ajkd.1998.v32.pm9740171","article-title":"De novo minimal change disease.","volume":"32","author":"Markowitz","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R4-20-20230601","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1034\/j.1399-0012.2002.02023.x","article-title":"De novo minimal change disease associated with reversible post-transplant nephrotic syndrome. A report of five cases and review of literature.","volume":"16","author":"Zafarmand","year":"2002","journal-title":"Clin Transplant"},{"key":"R5-20-20230601","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1399-0012.2012.01645.x","article-title":"De novo minimal change disease after ABO-incompatible kidney transplantation.","volume":"26","author":"Mochizuki","year":"2012","journal-title":"Clin Transplant"},{"key":"R6-20-20230601","first-page":"266","article-title":"Late de novo minimal change disease in a renal allograft.","volume":"20","author":"Madhan","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R7-20-20230601","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","article-title":"Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.","volume":"5","author":"McCarthy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R8-20-20230601","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"R9-20-20230601","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome.","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest"},{"key":"R10-20-20230601","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/01.tp.0000181385.68835.a0","article-title":"Sirolimus use and de novo minimal change nephropathy following renal transplantation.","volume":"80","author":"Mainra","year":"2005","journal-title":"Transplantation"},{"key":"R11-20-20230601","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/01.ASN.0000028249.06596.CF","article-title":"Molecular identification of SV40 infection in human subjects and possible association with kidney disease.","volume":"13","author":"Li","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R12-20-20230601","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.2215\/CJN.01060307","article-title":"Parvovirus B19 and the kidney.","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R13-20-20230601","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","article-title":"Nephrotoxicity of immunosuppressive drugs: New insight and preventive strategies.","volume":"7","author":"Olyaei","year":"2001","journal-title":"Curr Opin Crit Care"},{"key":"R14-20-20230601","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.03751106","article-title":"High sirolimus levels may induce focal segmental glomerulosclerosis de novo.","volume":"2","author":"Letavernier","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-20-20230601","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ndt\/gfn574","article-title":"Sirolimus interacts with pathways essential for podocyte integrity.","volume":"24","author":"Letavernier","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R16-20-20230601","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0272-6386(99)70400-2","article-title":"Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: Implications for graft survival.","volume":"34","author":"Cosio","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R17-20-20230601","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/1319-2442.106231","article-title":"Focal and segmental glomerulosclerosis in renal allograft recipients: A clinico-pathologic study of 37 cases.","volume":"24","author":"Gupta","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R18-20-20230601","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"R19-20-20230601","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/00007890-199805150-00009","article-title":"De novo collapsing glomerulopathy in renal allografts.","volume":"65","author":"Meehan","year":"1998","journal-title":"Transplantation"},{"key":"R20-20-20230601","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0971-4065.75220","article-title":"Collapsing glomerulopathy in renal allograft biopsies: A study of nine cases.","volume":"21","author":"Gupta","year":"2011","journal-title":"Indian J Nephrol"},{"key":"R21-20-20230601","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ndt\/18.1.187","article-title":"Acute cytomegalovirus infection complicated by collapsing glomerulopathy.","volume":"18","author":"Tomlinson","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R22-20-20230601","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/00007890-199712270-00037","article-title":"Parvovirus B19 infection-related complications in renal transplant recipients: Treatment with intravenous immunoglobulin.","volume":"64","author":"Moudgil","year":"1997","journal-title":"Transplantation"},{"key":"R23-20-20230601","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMc1207233","article-title":"Angiotensin antibodies and focal segmental glomerulosclerosis.","volume":"368","author":"Alachkar","year":"2013","journal-title":"N Engl J Med"},{"key":"R24-20-20230601","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/ndt\/gfl225","article-title":"Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.","volume":"21","author":"Swaminathan","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R25-20-20230601","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease.","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med"},{"key":"R26-20-20230601","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.transproceed.2009.01.042","article-title":"Recurent and de novo membranous glomerulopathy after kidney transplantation.","volume":"41","author":"Aline-Fardin","year":"2009","journal-title":"Transplant Proc"},{"key":"R27-20-20230601","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1432-2277.2012.01548.x","article-title":"De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease?","volume":"25","author":"Ponticelli","year":"2012","journal-title":"Transpl Int"},{"key":"R28-20-20230601","first-page":"249","article-title":"Membranous glomerulonephritis (MGN) in transplanted kidneys: Morphologic investigation on 256 renal allografts.","volume":"6","author":"Monga","year":"1993","journal-title":"Mod Pathol"},{"key":"R29-20-20230601","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.transproceed.2011.10.042","article-title":"Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts.","volume":"43","author":"Kearney","year":"2011","journal-title":"Transplant Proc"},{"key":"R30-20-20230601","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/TP.0b013e31828a947b","article-title":"Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy.","volume":"95","author":"Larsen","year":"2013","journal-title":"Transplantation"},{"key":"R31-20-20230601","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0272-6386(89)80189-1","article-title":"De novo membranous glomerulonephropathy in renal allografts: A report of ten cases and review of the literature.","volume":"14","author":"Truong","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"R32-20-20230601","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0272-6386(12)80493-8","article-title":"Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A.","volume":"17","author":"Schwarz","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"R33-20-20230601","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis\u2014a new look at an old entity.","volume":"366","author":"Sethi","year":"2012","journal-title":"N Engl J Med"},{"key":"R34-20-20230601","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/00007890-199506270-00006","article-title":"De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.","volume":"59","author":"Roth","year":"1995","journal-title":"Transplantation"},{"key":"R35-20-20230601","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ndt\/11.supp4.54","article-title":"Glomerular disease during HCV infection in renal transplantation.","volume":"11","author":"Hammoud","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R36-20-20230601","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5414\/CNP69239","article-title":"Prevalence of cryoglobulinemia and autoimmunity markers in renal-transplant patients.","volume":"69","author":"Faguer","year":"2008","journal-title":"Clin Nephrol"},{"key":"R37-20-20230601","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-6143.2001.10212.x","article-title":"Hepatitis C virus infection and de novo glomerular lesions in renal allografts.","volume":"1","author":"Cruzado","year":"2001","journal-title":"Am J Transplant"},{"key":"R38-20-20230601","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000045944","article-title":"De novo fibrillary glomerulopathy in the renal allograft of a patient with systemic lupus erythematosus.","volume":"87","author":"Isaac","year":"2001","journal-title":"Nephron"},{"key":"R39-20-20230601","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0272-6386(12)80167-3","article-title":"De novo immunotactoid glomerulopathy of the renal allograft: Possible association with cytomegalovirus infection.","volume":"24","author":"Rao","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R40-20-20230601","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-0012.2005.00403.x","article-title":"Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.","volume":"19","author":"Moriyama","year":"2005","journal-title":"Clin Transplant"},{"key":"R41-20-20230601","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1046\/j.1523-1755.63.6s.2.x","article-title":"Incidence of latent mesangial IgA deposition in renal allograft donors in Japan.","volume":"63","author":"Suzuki","year":"2003","journal-title":"Kidney Int"},{"key":"R42-20-20230601","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1399-0012.2004.00206.x","article-title":"The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.","volume":"18","author":"Ji","year":"2004","journal-title":"Clin Transplant"},{"key":"R43-20-20230601","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.ajkd.2004.09.030","article-title":"IgA nephropathy with crescents in kidney transplant recipients.","volume":"45","author":"Kowalewska","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R44-20-20230601","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1600-6135.2003.00283.x","article-title":"Acute post-bacterial glomerulonephritis in renal transplant patients: Description of three cases and review of the literature.","volume":"4","author":"Moroni","year":"2004","journal-title":"Am J Transplant"},{"key":"R45-20-20230601","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/01.tp.0000232327.09757.7b","article-title":"Postinfectious glomerulonephritis in renal allograft recipients.","volume":"82","author":"Plumb","year":"2006","journal-title":"Transplantation"},{"key":"R46-20-20230601","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1073\/pnas.0601436103","article-title":"Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.","volume":"103","author":"Sugimoto","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R47-20-20230601","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/ajkd.2002.31997","article-title":"Renal transplant in patients with Alport\u2019s syndrome.","volume":"39","author":"Byrne","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R48-20-20230601","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1523-1755.2000.00146.x","article-title":"High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.","volume":"58","author":"Rutgers","year":"2000","journal-title":"Kidney Int"},{"key":"R49-20-20230601","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen.","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"R50-20-20230601","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa0910500","article-title":"Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.","volume":"363","author":"Pedchenko","year":"2010","journal-title":"N Engl J Med"},{"key":"R51-20-20230601","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2215\/CJN.02190312","article-title":"Outcomes of male patients with Alport syndrome undergoing renal replacement therapy.","volume":"7","author":"Temme","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R52-20-20230601","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1016\/S0272-6386(00)70222-8","article-title":"De novo ANCA-associated vasculitis occurring 14 years after kidney transplantation.","volume":"35","author":"Asif","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R53-20-20230601","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0049-0172(00)80014-1","article-title":"Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: Update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.","volume":"29","author":"Schultz","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"R54-20-20230601","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0012.2009.01010.x","article-title":"Two cases of ANCA-associated vasculitis in post-transplant kidney: Relapse and de novo.","volume":"23","author":"Tabata","year":"2009","journal-title":"Clin Transplant"},{"key":"R55-20-20230601","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00007890-200301150-00012","article-title":"Recurrent and de novo diabetic nephropathy in renal allografts.","volume":"75","author":"Bhalla","year":"2003","journal-title":"Transplantation"},{"key":"R56-20-20230601","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semnephrol.2007.01.012","article-title":"Histopathology of diabetic nephropathy.","volume":"27","author":"Fioretto","year":"2007","journal-title":"Semin Nephrol"},{"key":"R57-20-20230601","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"key":"R58-20-20230601","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007890-199102000-00014","article-title":"Diabetes mellitus after renal transplantation in the cyclosporine era\u2014an analysis of risk factors.","volume":"51","author":"Sumrani","year":"1991","journal-title":"Transplantation"},{"key":"R59-20-20230601","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.TP.0000157870.21957.E5","article-title":"Tacrolimus and posttransplant diabetes mellitus in renal transplantation.","volume":"79","author":"van Hooff","year":"2005","journal-title":"Transplantation"},{"key":"R60-20-20230601","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data.","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"R61-20-20230601","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients.","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R62-20-20230601","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.trre.2013.06.001","article-title":"Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation.","volume":"27","author":"Peddi","year":"2013","journal-title":"Transplant Rev (Orlando"},{"key":"R63-20-20230601","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1432-2277.2009.00996.x","article-title":"Impact of glucose metabolism abnormalities on histopathological changes in kidney transplant protocol biopsies.","volume":"23","author":"Helanter\u00e4","year":"2010","journal-title":"Transpl Int"},{"key":"R64-20-20230601","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2337\/dc06-9912","article-title":"Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.","volume":"29","author":"Nathan","year":"2006","journal-title":"Diabetes Care"},{"key":"R65-20-20230601","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007890-199802150-00014","article-title":"Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes?","volume":"65","author":"Miles","year":"1998","journal-title":"Transplantation"},{"key":"R67-20-20230601","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"R68-20-20230601","first-page":"CD008143","article-title":"Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.","volume":"11","author":"Hemmingsen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R69-20-20230601","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy.","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"R70-20-20230601","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States.","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R71-20-20230601","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1600-6143.2003.00222.x","article-title":"Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation.","volume":"3","author":"Karthikeyan","year":"2003","journal-title":"Am J Transplant"},{"key":"R72-20-20230601","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","article-title":"Cyclosporine-associated thrombotic microangiopathy in renal allografts.","volume":"55","author":"Zarifian","year":"1999","journal-title":"Kidney Int"},{"key":"R73-20-20230601","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.transproceed.2012.07.039","article-title":"De novo thrombotic microangiopathy after kidney transplantation: Clinical features, treatment, and long-term patient and graft survival.","volume":"44","author":"Caires","year":"2012","journal-title":"Transplant Proc"},{"key":"R74-20-20230601","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5414\/CNP67335","article-title":"De novo thrombotic microangiopathy. An underrated complication of renal transplantation.","volume":"67","author":"Ponticelli","year":"2007","journal-title":"Clin Nephrol"},{"key":"R75-20-20230601","first-page":"609","article-title":"Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.","volume":"18","author":"Pratap","year":"2007","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R76-20-20230601","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","article-title":"Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys.","volume":"5","author":"Sartelet","year":"2005","journal-title":"Am J Transplant"},{"key":"R77-20-20230601","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","article-title":"De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.","volume":"10","author":"Satoskar","year":"2010","journal-title":"Am J Transplant"},{"key":"R78-20-20230601","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","article-title":"Thrombotic microangiopathy after kidney transplantation.","volume":"19","author":"Ponticelli","year":"2006","journal-title":"Transpl Int"},{"key":"R79-20-20230601","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1399-0012.2011.01454.x","article-title":"A case of progressive thrombotic microangiopathy after ABO-incompatible renal transplantation.","volume":"25","author":"Miura","year":"2011","journal-title":"Clin Transplant"},{"key":"R80-20-20230601","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","article-title":"Cyclosporine nephrotoxicity.","volume":"23","author":"Burdmann","year":"2003","journal-title":"Semin Nephrol"},{"key":"R81-20-20230601","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1681\/ASN.2012111064","article-title":"Cyclosporine induces endothelial cell release of complement-activating microparticles.","volume":"24","author":"Renner","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R82-20-20230601","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/ndt\/gfl340","article-title":"Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.","volume":"21","author":"Keller","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R83-20-20230601","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R84-20-20230601","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0041-1345(00)00940-4","article-title":"Thrombotic microangiopathy early after kidney transplantation: Hemolytic uremic syndrome or vascular rejection?","volume":"32","author":"Mor","year":"2000","journal-title":"Transplant Proc"},{"key":"R85-20-20230601","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/TP.0b013e318230c0bd","article-title":"Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab.","volume":"92","author":"Wilson","year":"2011","journal-title":"Transplantation"},{"key":"R86-20-20230601","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.transproceed.2011.02.064","article-title":"Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation\u2014a case report.","volume":"43","author":"Chandran","year":"2011","journal-title":"Transplant Proc"},{"key":"R87-20-20230601","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.transproceed.2012.03.053","article-title":"Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant.","volume":"44","author":"Stewart","year":"2012","journal-title":"Transplant Proc"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201408000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:21Z","timestamp":1786369461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201408000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":86,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.12571213","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}